Application effect of mobile healthcare on gestational diabetes mellitus patients:a meta-analysis

LIAO Rong; LUO Yaoyue; LI Yamin; YANG Hui

doi:10.3969/j.issn.1674-3806.2024.04.20

Abstract：Objective To evaluate the application effect of mobile healthcare on gestational diabetes mellitus(GDM)patients by using meta-analysis.Methods The Chinese and English databases such as PubMed,Embase,the Cochrane Library,Web of Science,China National Knowledge Infrastructure(CNKI),Wanfang Data Knowledge Service Platform and VIP Journals Resource Integration Service Platform(VIP)were retrieved by using a computer.Randomized controlled trial(RCT)literature about the application effect of mobile healthcare on GDM patients from the time when the databases were established to November 2023 was retrieved.A meta-analysis was performed by using Review Manager 5.4 and STATA 17.0 statistical software after 2 researchers independently screened the literature,extracted information and evaluated the quality of the included literature.Results A total of 16 papers were included,in which 2 394 GDM patients were included.The results of the meta-analysis showed that compared with the control group,the experimental group had low levels of fasting blood glucose[MD(95％CI)=-0.99(-1.64--0.35)],glycated hemoglobin[MD(95％CI)=-0.60(-0.93--0.27)],value of weight gain[MD(95％CI)=-1.09(-2.13--0.05)],risk of cesarean section[OR(95％CI)=0.61(0.46-0.82)],risk of macrosomia[OR(95％CI)=0.38(0.24-0.59)]and risk of hypoglycemia in newborns[OR(95％CI)=0.41(0.28-0.61)],and the differences were statistically significant(P＜0.05).The results of subgroup analysis showed that different intervention types of mobile healthcare could reduce the levels of fasting blood glucose and glycated hemoglobin in the GDM patients,and the differences were statistically significant(P＜0.05).Conclusion Mobile healthcare can reduce the levels of fasting blood glucose and glycated hemoglobin,and the risk of adverse preg-nancy outcomes in GDM patients,and is worthy of clinical promotion.